Sima Lev reccomends: Regulation of the epithelial control gene p63 by oncogenes and the Hippo signaling pathway
MOROSS – Integrated Cancer Center (MICC) cellpress https://weizmann.zoom.us/j/5065402023?pwd=a3Z6KzRCU0xJaUFoM2Y5emZwZm1oZz09
Publications
Sima lev recommend: PYK2, a hub of signaling networks in breast cancer progression
Trends In Cell Biology cellpress https://authors.elsevier.com/a/1hb3t3QxxSr7Kn
Sima lev recommend: Early-Stage Triple-Negative Breast Cancer: Optimizing Therapy
Breast Cancer: Optimizing Therapy THE ASCO POST Continue
Sima lev recommend: Updates in Triple-Negative Breast Cancer Treatment
Oncology Nursing News, February 2023 Oncology nurses provide perspective on the changing standards of care for patients with triple-negative breast cancer. Continue
Sima Lev’s lab – Combination Therapy & Drug Resistance
Combination Therapy & Drug Resistance TNBC – Triple-Negative Breast Cancer – accounts for approximately 20 percent of all breast cancer patients and can be divided […]
Accelerating AXL targeting for TNBC therapy Lohit Khera, Sima Lev
First described by electron microscopists in the early 60s the ER-Golgi contact sites in mammalian cells have remained The tyrosine kinase receptor AXL of the […]
The Golgi Apparatus and Membrane Contact Sites
First described by electron microscopists in the early 60s the ER-Golgi contact sites in mammalian cells have remained unexplored for forty years when the discovery […]
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
Sima Lev – Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot (sima.lev@weizmann.ac.il) Targeting of estrogen receptor is commonly used as afirst-line treatment for hormone-positive […]
